The Saudi Food and Drug Authority (SFDA) has announced the adoption of three new technical regulations to promote public ...

When you stop taking the miracle weight-loss drug, the cravings return—for food, yes, but also for something more.

The 2022 crash that killed Dominic Russo, 20, and Davion Flanagan, 19, and sent Russo’s 17-year-old girlfriend to prison is ...

Eli Lilly is just wrapping up trials of its retatrutide, but consumers already are flocking to black-market versions. Can Lilly compete with copies of its own drug?

Experts have found a new type of cholesterol. And it could be the most dangerous ...

Confirmatory Phase 3 trial of roluperidone for negative symptoms of schizophrenia initiated and first patient screenedPrevious open label trial ...

In 2012, neuroscientist Gary Landreth and his team at Case Western Reserve University published a finding in Science that ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 5:20 PM EDTCompany ParticipantsJoel Sendek - CFO ...

Avalyn opened at $26, above its $18 IPO price, giving the rare lung disease biotech a market value of about $1.1 billion.

IMCIVREE® (setmelanotide) launched in the U.S. for acquired hypothalamic obesity; more than 150 patient start forms received in the first six ...

Immunovant's underlying bull case has now moved away from batoclimab and toward IMVT-1402. Find out why IMVT stock is upgraded to buy.

IMVT-1402 showed clinically meaningful response rates of 72.7% ACR20, 54.5% ACR50 and 35.8% ACR70 at Week 16 in the open label period of its trial in difficult-to-treat rheumatoid arthritis (D2T RA); ...